All studies
Ongoing, recruitingTherapeutic use (Phase IV)Interventional

A phase IV randomised, double-blind, parallel-design, controlled multi-center trial of a NOVel moisturiser for Atopic dermatitis: effect on relapse prevention in children, NOVA II

At a glance

Status
Ongoing, recruiting
Phase
Therapeutic use (Phase IV)
Sponsor
Aco Hud Nordic AB
Enrolment target
270
Start
06 Dec 2022

What is this study about?

Relapse of atopic eczema, measured as a hazard ratio. Definition of relapse is an episode that, from the participants/participants’ parent(s) and/or legal guardian(s)’s perspective, requires escalation of treatment of the study area eczemas. Date of relapse will be noted in the eDiary and confirmed by the Investigator.

Who may be eligible?

Age any to any · Sex: All

Locations (2)

  • Germany
  • Sweden

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.